Memantine HCl 5 mg (28) / 10 mg (21) Tablet Titration Pack
RxNorm 996572
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 996572 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: memantine HCl 5 mg (28) / 10 mg (21) Tablet Titration Pack.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Memantine HCl 5 mg (28) / 10 mg (21) Tablet Titration Pack
(Atom ID: 7251062)
SYPrescribable
Synonym (SY):
Memantine HCl 5 mg (28) / 10 mg (21) Tablet Titration Pack
(Atom ID: 7251063)
GPCKPrescribable
Generic Pack (GPCK):
{21 (memantine hydrochloride 10 mg Oral Tablet) / 28 (memantine hydrochloride 5 mg Oral Tablet) } Pack
(Atom ID: 12372546)
Patient Education
Memantine
Memantine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal activity in the brain. Memantine may improve the ability to think and remember or may slow the loss of these abilities in people who have AD. However, memantine will not cure AD or prevent the loss of these abilities at some time in the future.
[Learn More]
* Please review the disclaimer below.